DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

On: September 25, 2024

Image

Cannabis News
September 25, 2024

The DEA announces increased production quotas for psilocybin, psilocin and ibogaine for research purposes. The Drug Enforcement Administration (DEA) has unveiled new production quotas for Schedule I and II controlled substances, with a notable emphasis on boosting the supply of certain psychedelics

Recreational Marijuana News

by Juan Spínelli

Read More: DEA Boosts Psychedelics Production For Research, Cannabis Quotas Hold Steady Ahead Of Rescheduling

Previous Post: Experts Issue 'Urgent' Warning Over Biden-Harris Cannabis Plans

Next Post: Gov. Newsom's Hemp Ban Goes Into Effect: Consequences For Industry, Investors, Patients

Comments are closed, but trackbacks and pingbacks are open.